- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/38 - Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Patent holdings for IPC class C07D 213/38
Total number of patents in this class: 661
10-year publication summary
44
|
50
|
42
|
39
|
56
|
36
|
46
|
25
|
35
|
12
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Samsung Display Co., Ltd. | 30585 |
16 |
Molecular Insight Pharmaceuticals, Inc. | 56 |
15 |
Centre National de La Recherche Scientifique | 9632 |
13 |
Bristol-myers Squibb Company | 5080 |
12 |
Merck Patent GmbH | 5909 |
10 |
Genentech, Inc. | 3742 |
9 |
The Governing Council of The University of Toronto, | 1361 |
9 |
Novartis AG | 11238 |
7 |
Gilead Sciences, Inc. | 1879 |
7 |
Oryzon Genomics S.A. | 103 |
7 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
7 |
Shaanxi Lighte Optoelectronics Material Co., Ltd. | 190 |
7 |
Atrogi AB | 41 |
6 |
Curis, Inc. | 130 |
6 |
Institut Curie | 531 |
6 |
Mycovia Pharmaceuticals, Inc. | 40 |
6 |
AstraZeneca AB | 3042 |
5 |
Janssen Pharmaceutica N.V. | 3839 |
5 |
Bayer Cropscience AG | 2241 |
5 |
The Johns Hopkins University | 5377 |
5 |
Other owners | 498 |